Metadherin Mediates Lipopolysaccharide-Induced Migration and Invasion of Breast Cancer Cells

Yuhan Zhao; Xiaoli Kong; Xiaoyan Li; Shi Yan; Cunzhong Yuan; Wenwei Hu; Qifeng Yang
December 2011
PLoS ONE;2011, Vol. 6 Issue 12, p1
Academic Journal
Background Breast cancer is the most prevalent cancer in women worldwide and metastatic breast cancer has very poor prognosis. Inflammation has been implicated in migration and metastasis of breast cancer, although the exact molecular mechanism remains elusive. Principal Findings We show that the pro-inflammatory endotoxin Lipopolysaccharide (LPS) upregulates the expression of Metadherin (MTDH), a recently identified oncogene, in a number of breast cancer lines. Stable knockdown of MTDH by shRNA in human breast MDA-MB-231 cells abolishes LPS-induced cell migration and invasion as determined by several in vitro assays. In addition, knockdown of MTDH diminishes Nuclear Factor-kappa B (NF-κB) activation by LPS and inhibited LPS-induced IL-8 and MMP-9 production. Conclusions These results strongly suggest that MTDH is a pivotal molecule in inflammation-mediated tumor metastasis. Since NF-κB, IL-8 and MMP-9 play roles in LPS-induced invasion or metastasis, the mechanism of MTDH-promoted invasion and metastasis may be through the activation of NF-κB, IL-8 and MMP-9, also suggesting a role of MTDH in regulating both inflammatory responses and inflammation-associated tumor invasion. These findings indicate that MTDH is involved in inflammation-induced tumor progression, and support that MTDH targeting therapy may hold promising prospects in treating breast cancer.


Related Articles

  • Cancer Transcriptomics: Modeling metastasis. Ramaswamy, Sridhar // European Journal of Human Genetics;Jan2006, Vol. 14 Issue 1, p1 

    The article comments on the use of microarrays in the identification of genes that may play a role in mediating breast cancer metastasis to the lung. The molecular basis of metastasis is poorly understood due to the complexity of the metastatic phenotype. The use of whole-tumor molecular...

  • Clinical and Ultrasonographic Characteristics of Breast Metastases from Extramammary Malignancies. Chun-Nan Yeh; Cheng-Hung Lin; Miin-Fu Chen // American Surgeon;Apr2004, Vol. 70 Issue 4, p287 

    Breast metastases from extramammary malignancies are uncommon, constituting about 2 per cent of all breast tumors. Breast metastasis may be confused with primary benign or malignant neoplasm of the breast. An accurate diagnosis of breast metastasis is important because the treatment and outcome...

  • Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer. Yamaki, Sayaka; Fujii, Takaaki; Yajima, Reina; Hirakata, Tomoko; Yamaguchi, Satoru; Fujisawa, Tomomi; Tsutsumi, Soichi; Asao, Takayuki; Yanagita, Yasuhiro; Iijima, Misa; Kuwano, Hiroyuki // Surgery Today;Aug2013, Vol. 43 Issue 8, p901 

    Purpose: Galectin-3 expression is modulated in cancer cells, and that finding has led to the recognition of galectin-3 as a diagnostic or prognostic marker for various cancers, including breast cancer. This study investigated the correlation between galectin-3 expression and the...

  • Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Zavagno, Giorgio; Carcoforo, Paolo; Marconato, Renato; Franchini, Zeno; Scalco, Giuliano; Burelli, Paolo; Pietrarota, Paolo; Lise, Mario; Mencarelli, Roberto; Capitanio, Giovanni; Ballarin, Andrea; Pierobon, Maria Elena; Marconato, Giorgia; Nitti, Donato // BMC Cancer;2005, Vol. 5, p28 

    Background: Sentinel lymph node (SLN) biopsy is an effective tool for axillary staging in patients with invasive breast cancer. This procedure has been recently proposed as part of the treatment for patients with ductal carcinoma in situ (DCIS), because cases of undetected invasive foci and...

  • To grow and spread. McCarthy, Nicola // Nature Reviews Cancer;May2007, Vol. 7 Issue 5, p324 

    The article highlights the previous research, which identified a lung metastasis gene-expression signature (LMS) in human breast cancer cells, of which a subset of genes supports both primary tumor growth and metastasis, whereas others support just metastasis. The present article tries to...

  • Applications of Cellular Systems Biology in Breast Cancer Patient Stratification and Diagnostics. Critchley-Thorne, Rebecca J.; Miller, Steven M.; Taylor, D. Lansing; Lingle, Wilma L. // Combinatorial Chemistry & High Throughput Screening;Nov2009, Vol. 12 Issue 9, p860 

    Tumors are complex structures of malignant cells and stromal cells that function as an integrated system that promotes tumor progression. Immune cells and other stromal components serve vital cooperative functions that often support tumor growth and metastasis; stromal content and function are...

  • ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling. Masuda, Tetsuro; Endo, Motoyoshi; Yamamoto, Yutaka; Odagiri, Haruki; Kadomatsu, Tsuyoshi; Nakamura, Takayuki; Tanoue, Hironori; Ito, Hitoshi; Yugami, Masaki; Miyata, Keishi; Morinaga, Jun; Horiguchi, Haruki; Motokawa, Ikuyo; Terada, Kazutoyo; Morioka, Masaki Suimye; Manabe, Ichiro; Iwase, Hirotaka; Mizuta, Hiroshi; Oike, Yuichi // Scientific Reports;3/20/2015, p9170 

    Bone metastasis of breast cancer cells is a major concern, as it causes increased morbidity and mortality in patients. Bone tissue-derived CXCL12 preferentially recruits breast cancer cells expressing CXCR4 to bone metastatic sites. Thus, understanding how CXCR4 expression is regulated in breast...

  • Breast cancer brain metastases: new directions in systemic therapy. Lin, Nancy U. // Ecancermedicalscience;2013, Vol. 7, p1 

    The management of patients with brain metastases from breast cancer continues to be a major clinical challenge. The standard initial therapeutic approach depends upon the size, location, and number of metastatic lesions and includes consideration of surgical resection, whole-brain radiotherapy,...

  • The role of surgical resection in patients with brain metastases. Aziz Hatiboglu, Mustafa; Wildrick, David M.; Sawaya, Raymond // Ecancermedicalscience;2013, Vol. 7, p1 

    Brain metastasis is a devastating complication of systemic malignancy that affects a considerable number of cancer patients. The appearance of brain metastases is often considered to be a sign of poor prognosis; in patients with brain metastases poor survival time has been reported in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics